ESTIMATION OF LIVER IRON CONCENTRATION BY SERUM FERRITIN MEASUREMENT IN NON-TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS: ANALYSIS FROM THE 1-YEAR THALASSA STUDY

被引：0
|
作者：
Taher, A. [1 ]
Porter, J. [2 ]
Viprakasit, V. [3 ]
Kattamis, A. [4 ]
Chuncharunee, S. [5 ]
Sutcharitchan, P. [6 ,7 ]
Siritanaratkul, N. [3 ]
Galanello, R. [8 ]
Karakas, Z. [9 ]
Lawniczek, T. [10 ]
Habr, D. [11 ]
Ros, J. [10 ]
Zhang, Y. [11 ]
Cappellini, D. [12 ]
机构：
[1] Amer Univ Beirut, Beirut, Lebanon
[2] UCL, London, England
[3] Mahidol Univ, Siriraj Hosp, Bangkok, Thailand
[4] Univ Athens, Dept Pediat 1, Athens, Greece
[5] Mahidol Univ, Ramathibodi Hosp, Bangkok, Thailand
[6] Chulalongkorn Univ, Bangkok, Thailand
[7] King Chulalongkorn Mem Hosp, Bangkok, Thailand
[8] Univ Cagliari, Osped Reg Microcitemie, Cagliari, Italy
[9] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey
[10] Novartis Pharma AG, Basel, Switzerland
[11] Novartis Pharmaceut, E Hanover, NJ USA
[12] Univ Milan, Ca Granda Fdn IRCCS, Milan, Italy
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0927
引用
收藏
页码：383 / 383
页数：1
相关论文
共 50 条
  • [1] REDUCTION IN LIVER IRON CONCENTRATION IS CONSISTENT ACROSS SUBGROUPS OF NON-TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS TREATED WITH DEFERASIROX: RESULTS FROM THE 1-YEAR THALASSA STUDY
    Taher, A.
    Porter, J.
    Viprakasit, V.
    Kattamis, A.
    Chuncharunee, S.
    Sutcharitchan, P.
    Siritanaratkul, N.
    Galanello, R.
    Karakas, Z.
    Lawniczek, T.
    Habr, D.
    Ros, J.
    Zhang, Y.
    Cappellini, D.
    HAEMATOLOGICA, 2012, 97 : 381 - 382
  • [2] Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study
    Taher, Ali T.
    Porter, John B.
    Viprakasit, Vip
    Kattamis, Antonis
    Chuncharunee, Suporn
    Sutcharitchan, Pranee
    Siritanaratkul, Noppadol
    Galanello, Renzo
    Karakas, Zeynep
    Lawniczek, Tomasz
    Habr, Dany
    Ros, Jacqueline
    Zhu, Zewen
    Cappellini, M. Domenica
    ANNALS OF HEMATOLOGY, 2013, 92 (11) : 1485 - 1493
  • [3] Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study
    Ali T. Taher
    John B. Porter
    Vip Viprakasit
    Antonis Kattamis
    Suporn Chuncharunee
    Pranee Sutcharitchan
    Noppadol Siritanaratkul
    Renzo Galanello
    Zeynep Karakas
    Tomasz Lawniczek
    Dany Habr
    Jacqueline Ros
    Zewen Zhu
    M. Domenica Cappellini
    Annals of Hematology, 2013, 92 : 1485 - 1493
  • [4] Correlation of Liver and Myocardium Iron Concentration Determined by Magnetic Resonance Imaging With Serum Ferritin in Non-Transfusion-Dependent Thalassemia Patients
    Gayathri, Nagenthran
    Kumar, M. Vasantha
    Vinoth, Thangam
    Prabhu, Radhan
    Krishnabharath, S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (07)
  • [5] Deferasirox Significantly Reduces Liver Iron Concentration In Non-Transfusion-Dependent Thalassemia Patients with Iron Overload: Results From the 1-Year Randomized, Double-Blind, Placebo-Controlled Phase II THALASSA Study
    Taher, Ali T.
    Porter, John B.
    Viprakasit, Vip
    Kattamis, Antonis
    Chuncharunee, Suporn
    Sutcharitchan, Pranee
    Siritanaratkul, Noppodol
    Galanello, Renzo
    Karakas, Zeynep
    Lawniczek, Tomasz
    Ros, Jacqueline
    Zhang, Yiyun
    Habr, Dany
    Cappellini, M. Domenica
    BLOOD, 2011, 118 (21) : 412 - 413
  • [6] CHANGES IN ALTERNATIVE IRON OVERLOAD PARAMETERS FOLLOWING 1 YEAR OF DEFERASIROX THERAPY IN PATIENTS WITH NON-TRANSFUSION-DEPENDENT THALASSEMIA: A LONGITUDINAL ANALYSIS FROM THE THALASSA STUDY
    Porter, J. B.
    Cappellini, M. D.
    Kattamis, A.
    Viprakasit, V.
    Musallam, K. M.
    Zhu, Z.
    Taher, A. T.
    HAEMATOLOGICA, 2014, 99 : 441 - 442
  • [7] SERUM FERRITIN FOR PREDICTING CLINICALLY RELEVANT LIC THRESHOLDS TO GUIDE MANAGEMENT OF PATIENTS WITH NON-TRANSFUSION-DEPENDENT THALASSEMIA TREATED WITH DEFERASIROX: THALASSA STUDY EXTENSION ANALYSIS
    Taher, A.
    Porter, J.
    Viprakasit, V.
    Kattamis, A.
    Chuncharunee, S.
    Sutcharitchan, P.
    Siritanaratkul, N.
    Galanello, R.
    Karakas, Z.
    Habr, D.
    Zhu, Z.
    Cappellini, M.
    HAEMATOLOGICA, 2013, 98 : 486 - 486
  • [8] The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non-transfusion-dependent thalassaemia patients
    Ricchi, Paolo
    Meloni, Antonella
    Spasiano, Anna
    Costantini, Silvia
    Pepe, Alessia
    Cinque, Patrizia
    Filosa, Aldo
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (05) : 721 - 726
  • [9] Efficacy and Safety of Deferasirox in Chinese Patients with Non-Transfusion-Dependent Thalassemia: 1-Year Results from the Thetis Study
    Lai, Yong-Rong
    Liu, Rong Rong
    Cappeilini, M. Domenica
    Aydinok, Yesim
    Porter, John B.
    Zhu, Zewen
    Wang, Candace
    Qi, Xue
    Taher, Ali T.
    BLOOD, 2015, 126 (23)
  • [10] Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS study
    Taher, Ali T.
    Cappellini, M. Domenica
    Aydinok, Yesim
    Porter, John B.
    Karakas, Zeynep
    Viprakasit, Vip
    Siritanaratkul, Noppadol
    Kattamis, Antonis
    Wang, Candace
    Zhu, Zewen
    Joaquin, Victor
    Uwamahoro, Marie Jose
    Lai, Yong-Rong
    BLOOD CELLS MOLECULES AND DISEASES, 2016, 57 : 23 - 29
12345